Companies / United Kingdom
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
GSK Cuts HIV Drug Prices For Russia
September 2006 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
In effort to control the country's growing HIV/AIDS epidemic, UK firm GlaxoSmithKline (GSK) has entered into a deal with the Russian government to supply three of its antiretroviral drugs at discounted prices. The agreement is the first direct, federal purchase of HIV/AIDS medicines in